Conference Coverage
Videos
NewsNetwork
OncLive® TV
Peer Exchange
Insights
Attend An Event
State of the Science Summit
Regional Seminar Series
PER Conferences
Giants of Cancer Care
ISGIO
Webinars
OncLive Community
SPECIALTY TOPICS
CURRENTLY VIEWING
All Specialties
Breast Cancer
Multiple Myeloma
Lung Cancer
Immuno-Oncology News
Gynecologic Oncology
Gastrointestinal Cancer
Colorectal Cancer
Ovarian Cancer
Prostate Cancer
Precision Medicine in Oncology®
Neoadjuvant HER2+
More >>

Latest from Winship

Dr. Lonial on Treatments in Heavily Pretreated Multiple Myeloma
Sagar Lonial, MD, FACP, discusses treatments for patients with heavily pretreated multiple myeloma.
Dr. Cohen on the Use of Chemoimmunotherapy in CLL
Jonathon B. Cohen, MD, MS, discusses the role of chemoimmunotherapy in chronic lymphocytic leukemia. 
 
Dr. Owonikoko on Standard of Care for SCLC
Taofeek K. Owonikoko, MD, PhD, discusses current standard of care treatments for patients with small cell lung cancer.
Dr. Nooka on Treatment Options for Transplant-Eligible and -Ineligible Multiple Myeloma
Ajay K. Nooka, MD, MPH, FACP, discusses current options for transplant-eligible and -ineligible patients with multiple myeloma.
Dr. Gogineni on Implications of the APT Trial in HER2+ Breast Cancer
Keerthi Gogineni, MD, MSHP, discusses the clinical implications of the phase II APT trial in HER2-positive breast cancer.
Dr. Lonial on Treating Early Relapse in Multiple Myeloma
Sagar Lonial, MD, FACP, discusses the management of patients with relapsed multiple myeloma. 
 
NGS Testing Is Essential Before Induction in NSCLC
Suresh S. Ramalingam, MD, FASCO, highlights current and emerging therapies for 6 key actionable driver mutations in non–small cell lung cancer.
Dr. Ramalingam on FLAURA Trial Results in EGFR-Mutant NSCLC
Suresh S. Ramalingam, MD, FASCO, discusses updated data from the FLAURA trial in EGFR-mutant non–small cell lung cancer.
Next Page >>
Inside Oncology
View more videos >>
FDA Approval of a Biosimilar, Promising Data in Myeloma and GBM, and More
FDA Approval of a Biosimilar, Promising Data in Myeloma and GBM, and More
Update on NDA in GIST, Promising Data in Lung Cancer, KRAS G12C-Mutant Cancers, and AML, and European Approval in RCC
Update on NDA in GIST, Promising Data in Lung Cancer, KRAS G12C-Mutant Cancers, and AML, and European Approval in RCC
FDA Approvals in Ovarian Cancer and for MEC Chemo, Promising Data in Lung Cancer, and More
FDA Approvals in Ovarian Cancer and for MEC Chemo, Promising Data in Lung Cancer, and More
Publication Bottom Border
Border Publication
 
x